Use of changes in B-type natriuretic peptides to detect ischemia in selected patients

被引:7
|
作者
Staub, Daniel [1 ,2 ]
Jauslin, Daniel [1 ]
Freidank, Heike [3 ]
Taegtmeyer, Anne [1 ]
Breidthardt, Tobias [1 ]
Zellweger, Michael J. [1 ]
Mueller-Brand, Jan [4 ]
Christ, Michael [1 ]
Mueller, Christian [1 ]
机构
[1] Univ Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[2] Rush Univ, Med Ctr, Cardiol Sect, Dept Internal Med, Chicago, IL 60612 USA
[3] Univ Basel Hosp, Dept Lab Med, Basel, Switzerland
[4] Univ Basel Hosp, Dept Nucl Med, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Natriuretic peptides; Ischemia; Exercise; ST-SEGMENT ELEVATION; EMISSION COMPUTED-TOMOGRAPHY; INDUCED MYOCARDIAL-ISCHEMIA; CORONARY-ARTERY-DISEASE; HEART-FAILURE; PROGNOSTIC VALUE; ANGINA-PECTORIS; ACUTE DYSPNEA; CHEST-PAIN; EXERCISE;
D O I
10.1016/j.ijcard.2008.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is accumulating evidence that transient exercise-induced ischemia triggers the release of B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). The aim of this study was to either confirm or refute a previous investigation suggesting that myocardial ischemia can reliably be detected by exercise-induced changes in BNP or NT-proBNP levels in selected patients. Methods: A total of 139 consecutive patients with normal left ventricular function and normal resting BNP and NT-proBNP levels referred for rest/stress myocardial perfusion single-photon emission computed tomography (SPECT) were analyzed. Levels of BNP and NT-proBNP were determined before and immediately after symptom-limited bicycle ergometry. Results: Inducible myocardial ischemia on perfusion images was detected in 46 patients (33%). Median exercise-induced increases in BNP (Delta BNP) and NT-proBNP (Delta NT-proBNP) were similar in patients with and without inducible ischemia (Delta BNP 12.7 pg/ml vs. 9.4 pg/ml, p = 0.109; Delta NT-proBNP 7 pg/ml vs. 6 pg/ml, p = 0.309). The area under the receiver operating characteristic curve for the ability to detect myocardial ischemia was 0.583 (95% CI, 0.479-0.688) for Delta BNP, and 0.553 (95% CI, 0.450-0.656) for Delta NT-proBNP. Conclusions: Exercise-induced changes in BNP and NT-proBNP do not reliably detect myocardial ischemia in selected patients. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [31] Elevation of B-type natriuretic peptide in the setting of myocardial ischemia
    Sabatine, MS
    Morrow, DA
    De Lemos, JA
    Desai, MY
    Mannting, F
    Cooper, HA
    Antman, EM
    McCabe, CH
    Braunwald, E
    CIRCULATION, 2001, 104 (17) : 485 - 486
  • [32] Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
    Waldum, Bard
    Stubnova, Viera
    Westheim, Arne S.
    Omland, Torbjorn
    Grundtvig, Morten
    Os, Ingrid
    CLINICAL KIDNEY JOURNAL, 2013, 6 (01): : 55 - 62
  • [33] B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients
    Rinat, Choni
    Becker-Cohen, Rachel
    Nir, Amiram
    Feinstein, Sofia
    Algur, Nurit
    Ben-Shalom, Efrat
    Farber, Benjamin
    Frishberg, Yaacov
    PEDIATRIC NEPHROLOGY, 2012, 27 (04) : 617 - 625
  • [34] B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients
    Choni Rinat
    Rachel Becker-Cohen
    Amiram Nir
    Sofia Feinstein
    Nurit Algur
    Efrat Ben-Shalom
    Benjamin Farber
    Yaacov Frishberg
    Pediatric Nephrology, 2012, 27 : 617 - 625
  • [35] Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care
    Hill, Stephen A.
    Balion, Cynthia M.
    Santaguida, Pasqualina
    McQueen, Matthew J.
    Ismaila, Afisi S.
    Reichert, Sonja M.
    McKelvie, Robert
    Worster, Andrew
    Raina, Parminder S.
    CLINICAL BIOCHEMISTRY, 2008, 41 (4-5) : 240 - 249
  • [36] Secretion patterns of A-type and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or dilated cardiomyopathy
    Mizuno, Y
    Yoshimura, M
    Nakayama, M
    Harada, E
    Nakamura, S
    Ito, T
    CIRCULATION, 2000, 102 (18) : 504 - 504
  • [37] Use of B-type natriuretic peptide test - Response
    O'Connor, J
    Meurer, L
    JOURNAL OF FAMILY PRACTICE, 2003, 52 (04): : 310 - 310
  • [38] Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure
    Yoshimura, M
    Mizuno, Y
    Harada, E
    Nakayama, M
    Shimasaki, Y
    Ito, T
    Nakamura, S
    Soejima, H
    Miyamoto, S
    Takazoe, K
    Ogawa, H
    Kugiyama, K
    Saito, Y
    Nakao, K
    Yasue, H
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (09): : 1228 - 1233
  • [39] MECHANISM OF ACTION OF A-TYPE, B-TYPE AND C-TYPE NATRIURETIC PEPTIDES
    WEIR, ML
    PANG, SC
    FLYNN, TG
    FASEB JOURNAL, 1992, 6 (04): : A1235 - A1235
  • [40] The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea
    Mueller, C
    Laule-Kilian, K
    Frana, B
    Rodriguez, D
    Rudez, J
    Scholer, A
    Buser, P
    Pfisterer, M
    Perruchoud, AP
    JOURNAL OF INTERNAL MEDICINE, 2005, 258 (01) : 77 - 85